Developmental outcomes of infants born to women infected with SARS-CoV-2 during pregnancy.

Go Back to All Clinical Trials

Developmental outcomes of infants born to women infected with SARS-CoV-2 during pregnancy.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Development
Age: Between 0 - 3 Years
Gender: Male or Female

Other Inclusion Criteria:
1. Infants born at greater than 37 week gestational age at NYU Langone (Tisch Hospital) whose mothers tested positive for SARS-COV2 during the hospitalization for delivery

You may not be eligible for this study if the following are true:

1. Preterm infants (<37 weeks)
2. Major congenital anomalies that impact neurodevelopment
3. Genetic diagnosis that impact neurodevelopment

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies